Emily is a science journalist who writes about health, medicine and biotechnology. Most recently, she was the associate editor for biomedicine at MIT Technology Review. She now freelances and has been published in the Washington Post, Scientific American, Smithsonian Magazine, The Atlantic, Pacific Standard and the Baltimore Sun, among others.

She is drawn to stories with a strong human element and is interested in topics like drug development, rare diseases, neurodegenerative disorders, gene therapy, genomics, regenerative medicine, women's health, public health, AI in medicine and disparities in health and medicine. You can read recent examples of her work at www.emilymullin.com and read about her at her Linkedin